资讯

口服多肽疗法icotrokinra向FDA提交上市申请，药明康德参与合作开发
7月22日，药明康德（603259）在微信公众号平台透露，公司与强生（Johnson & Johnson）、Protagonist ...
十大明星分子之一！口服多肽向FDA递交上市申请
强生（Johnson & Johnson）与Protagonist ...
Microsoft3 年
Microsoft and Johnson & Johnson deepen their cooperation on the ...
November 6, 2021, Shanghai – Microsoft and Johnson & Johnson, the world’s leading healthcare company, announced that they will deepen cooperation in the Chinese market, at the 4 th International ...